Showing results (1191-1200 of 1,598) with videos related to
Sort By:
Pageof 160
Cancer Journal (Sudbury, Mass.)|March 25, 2022
Improving Equity in Cancer Care in the Face of a Public Health EmergencyKaren M Winkfield, Robert A WinnCancer Journal (Sudbury, Mass.)|July 24, 2026
Targeting Oncogenic Gene Fusions in Lung CancerYunan Nie, Frederick H WilsonCancer Journal (Sudbury, Mass.)|July 24, 2026
Early-Stage NSCLC: Novel Surgical Techniques and Neoadjuvant, Adjuvant, and Perioperative TherapiesSo Yeon Kim, Gavitt WoodardCancer Journal (Sudbury, Mass.)|January 26, 2011
Pretreatment assessment for the optimal management of early-stage lung cancerSandra C Tomaszek, Dennis A WigleCancer Journal (Sudbury, Mass.)|January 26, 2011
Evaluation of treatment response after nonoperative therapy for early-stage non-small cell lung carcinomaJilbert Eradat, Fereidoun Abtin, Antonio Gutierrez, et al.Cancer Journal (Sudbury, Mass.)|January 26, 2011
Predicting response to chemotherapy with early-stage lung cancerRafael Rosell, Miquel Taron, Bartomeu Massuti, et al.Cancer Journal (Sudbury, Mass.)|December 7, 2010
Impact of health care reform on medicare and dual medicare-medicaid beneficiariesKenneth E Thorpe, Meredith PhilyawCancer Journal (Sudbury, Mass.)|December 7, 2010
The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer databaseElizabeth M Ward, Stacey A Fedewa, Vilma Cokkinides, et al.Cancer Journal (Sudbury, Mass.)|December 7, 2010
Target inhibition in antiangiogenic therapy a wide spectrum of selectivity and specificityRonan J Kelly, Colleen Darnell, Olivier RixeCancer Journal (Sudbury, Mass.)|June 8, 2010
Biological rationale and current clinical experience with anti-insulin-like growth factor 1 receptor monoclonal antibodies in treating sarcoma: twenty years from the bench to the bedsideDavid Olmos, Daniel S W Tan, Robin L Jones, et al.Pageof 160